Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised “Two-Hit” Hypothesis
The rising prevalence of nonalcoholic fatty liver disease (NAFLD)-related cirrhosis highlights the need for a better understanding of the molecular mechanisms responsible for driving the transition of hepatic steatosis (fatty liver; NAFL) to steatohepatitis (NASH) and fibrosis/cirrhosis. Obesity-rel...
Main Authors: | Genta Kakiyama, Daniel Rodriguez-Agudo, William M. Pandak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/10/1434 |
Similar Items
-
Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
by: Kei Minowa, et al.
Published: (2023-05-01) -
Diverse Immunoregulatory Roles of Oxysterols—The Oxidized Cholesterol Metabolites
by: Chloe Choi, et al.
Published: (2020-09-01) -
25-Hydroxycholesterol 3-sulfate is an endogenous ligand of DNA methyltransferases in hepatocytes
by: Yaping Wang, et al.
Published: (2021-01-01) -
Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis
by: Yusuke Akiyama, et al.
Published: (2023-06-01) -
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
by: Charlotte Lefort, et al.
Published: (2021-02-01)